Comprehensive Novel Variant Discovery in Hereditary Cardiology and Neurology Research using Next-Generation Sequencing

11 SEPTEMBER 2018 11 SEPTEMBER 2018

We invite you to join our webinar on “Comprehensive Novel Variant Discovery in Hereditary Cardiology and Neurology Research using Next-Generation Sequencing"

Date: September 11, 2018
Time: 10:00 AM EST
Register Now

Dr. Todd Richmond presents insights on the development of Roche's newest SeqCap EZ  target enrichment panels for hereditary cardiology and neurology research. Created with expert-driven content to achieve more uniform target coverage and to increase sequencing efficiency, these panels aid in the discovery of novel disease-causing genetic variants. 

 

Speaker Biography


Dr. Todd Richmond

Dr. Richmond holds a PhD degree from the Department of Genetics at the University of Wisconsin-Madison. Todd joined RSS Madison (formerly Roche NimbleGen) in 2001 and is currently the Director of Research Informatics, responsible for providing bioinformatics and statistical support to the development and innovation teams. He has been a key contributor to Roche's innovative probe design methodologies for DNA capture, for both human and non-human products, as well as epigenetics and RNA expression product lines.

 

 
 

Research Use Only. Not for use in diagnostic procedures.
HYPERCAP, KAPA and SEQCAP are trademarks of Roche.

This XTalks webinar was sponsored by Roche Sequencing Solutions.